These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24724258)

  • 41. Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001.
    Masoudi FA; Gross CP; Wang Y; Rathore SS; Havranek EP; Foody JM; Krumholz HM
    Circulation; 2005 Jul; 112(1):39-47. PubMed ID: 15983243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
    Gheorghiade M; Gattis WA; Adams KF; Jaffe AS; O'Connor CM; ;
    Am Heart J; 2003 Feb; 145(2 Suppl):S55-7. PubMed ID: 12594453
    [No Abstract]   [Full Text] [Related]  

  • 43. New hope from a 40-year-old drug: deaths from heart failure cut by 30 percent.
    Comarow A
    US News World Rep; 1999 Aug; 127(5):69. PubMed ID: 10539698
    [No Abstract]   [Full Text] [Related]  

  • 44. [Chronic heart insufficiency should be treated also with spironolactone].
    Kjeldsen KP; Nørgaard A; Thygesen K
    Ugeskr Laeger; 1999 Sep; 161(37):5132. PubMed ID: 10523942
    [No Abstract]   [Full Text] [Related]  

  • 45. Spironolactone and congestive heart-failure.
    Georges B; Beguin C; Jadoul M
    Lancet; 2000 Apr; 355(9212):1369-70. PubMed ID: 10776778
    [No Abstract]   [Full Text] [Related]  

  • 46. Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?
    MacFadyen RJ; Ng Kam Chuen MJ; Davis RC
    Eur J Heart Fail; 2010 Jul; 12(7):649-52. PubMed ID: 20576834
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy of spironolactone therapy in patients with heart failure with normal ejection fraction.
    Ozhan H; Balaban Y
    Heart; 2010 May; 96(10):791; author reply 791. PubMed ID: 20448132
    [No Abstract]   [Full Text] [Related]  

  • 48. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age.
    Dinsdale C; Wani M; Steward J; O'Mahony MS
    Age Ageing; 2005 Jul; 34(4):395-8. PubMed ID: 15955761
    [No Abstract]   [Full Text] [Related]  

  • 50. Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure--SIGNAL-HF (Swedish Intervention study--Guidelines and NT-proBNP AnaLysis in Heart Failure).
    Persson H; Erntell H; Eriksson B; Johansson G; Swedberg K; Dahlström U
    Eur J Heart Fail; 2010 Dec; 12(12):1300-8. PubMed ID: 20876734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognosis in heart failure with a normal ejection fraction.
    Cleland JG; Taylor J; Tendera M
    N Engl J Med; 2007 Aug; 357(8):829-30. PubMed ID: 17715420
    [No Abstract]   [Full Text] [Related]  

  • 52. Old drug gets new life in treating congestive heart failure.
    Mayo Clin Health Lett; 2000 Apr; 18(4):4. PubMed ID: 10815555
    [No Abstract]   [Full Text] [Related]  

  • 53. What's old is new again. Spironolactone and heart failure.
    Lock M; Chun R
    Can Fam Physician; 1999 Nov; 45():2621-2. PubMed ID: 10587769
    [No Abstract]   [Full Text] [Related]  

  • 54. Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.
    Gallegos PJ; Maclaughlin EJ; Haase KK
    Pharmacotherapy; 2008 Mar; 28(3):343-55. PubMed ID: 18294114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Drug therapy of heart insufficiency guided by hormone measurements].
    Kjaer A; Haunsø S
    Ugeskr Laeger; 2001 Jan; 163(3):304. PubMed ID: 11219112
    [No Abstract]   [Full Text] [Related]  

  • 56. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
    MMW Fortschr Med; 2010 Dec; 152(48):12-3. PubMed ID: 21226226
    [No Abstract]   [Full Text] [Related]  

  • 57. Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levels in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitor.
    Ogawa S; Takeuchi K; Mori T; Nako K; Ito S
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):477-9. PubMed ID: 16700881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs.
    Schuller S; Van Israël N; Vanbelle S; Clercx C; McEntee K
    J Vet Pharmacol Ther; 2011 Aug; 34(4):322-31. PubMed ID: 20950346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of spironolactone use on heart failure mortality: a population-based study.
    Ouzounian M; Hassan A; Cox JL; Johnstone DE; Howlett J;
    J Card Fail; 2007 Apr; 13(3):165-9. PubMed ID: 17448412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Undertreatment of heart failure has high cost to patients.
    Berry C; McMurray J
    BMJ; 2001 Mar; 322(7288):731-2. PubMed ID: 11264218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.